sorafenib has been researched along with psammaplysin f in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (psammaplysin f) | Trials (psammaplysin f) | Recent Studies (post-2010) (psammaplysin f) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 7 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christen, KE; Davis, RA; Kennedy, D | 1 |
1 other study(ies) available for sorafenib and psammaplysin f
| Article | Year |
|---|---|
Psammaplysin F increases the efficacy of bortezomib and sorafenib through regulation of stress granule formation.
Topics: Animals; Bortezomib; Chlorocebus aethiops; Cytoplasmic Granules; Drug Resistance, Neoplasm; HEK293 Cells; HeLa Cells; Humans; MCF-7 Cells; Neoplasms; Sorafenib; Spiro Compounds; Tyrosine; Vero Cells | 2019 |